Informatics confronts drug-drug interactions

Trends in Pharmacological Sciences

Volumn 34, Issue 3, 2013, Pages 178-184

  Percha, Bethany ^a   Altman, Russ B ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ASTEMIZOLE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLARITHROMYCIN; CLOZAPINE; COLCHICINE; CYCLOSPORIN; ERYTHROMYCIN; FLUOROURACIL; FLUOXETINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; KETOCONAZOLE; METHYLPREDNISOLONE; MIBEFRADIL; PAROXETINE; PRAVASTATIN; PROPOFOL; SIMVASTATIN; SORIVUDINE; TERFENADINE; WARFARIN;

BRADYCARDIA; DATA BASE; DATA EXTRACTION; DATA MINING; DRUG DRUG INTERACTION; DRUG FATALITY; DRUG INFORMATION; DRUG INTERACTION; DRUG SURVEILLANCE PROGRAM; ELECTRONIC MEDICAL RECORD; FOOD DRUG INTERACTION; GASTROINTESTINAL HEMORRHAGE; GLUCOSE BLOOD LEVEL; GRAPEFRUIT JUICE; HEART VENTRICLE ARRHYTHMIA; HUMAN; INCIDENCE; INFORMATION SYSTEM; KNOWLEDGE BASE; MEDICAL INFORMATICS; PHARMACOGENOMICS; POLYPHARMACY; PREDICTIVE VALUE; PRIORITY JOURNAL; QT PROLONGATION; REVIEW; RHABDOMYOLYSIS; SCIENTIFIC LITERATURE; SIDE EFFECT; TACHYCARDIA; TOXIC MYOPATHY;

DRUG INTERACTIONS; HUMANS; INFORMATICS;

EID: 84874662621     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2013.01.006     Document Type: Review

References (57)

1. M.L. Becker Hospitalisations and emergency department visits due to drug-drug interactions: a literature review Pharmacoepidemiol. Drug Saf. 16 2007 641 651 (Pubitemid 47039530)
2. Centers for Disease Control/National Center for Health Statistics (2010) National Hospital Ambulatory Medical Care Survey 2009, Centers for Disease Control/National Center for Health Statistics
3. M.J. Hall National hospital discharge survey: 2007 summary Natl. Health Stat. Rep. 29 2010 1 20
4. C.S. Moura Drug-drug interactions associated with length of stay and cost of hospitalization J. Pharm. Pharm. Sci. 12 2009 266 272
5. National Center for Health Statistics (2012) Health, United States, 2011: With Special Feature on Socioeconomic Status and Health, National Center for Health Statistics
6. P. Broadhurst, and A.W. Nathan Cardiac arrest in a young woman with the long QT syndrome and concomitant astemizole ingestion Br. Heart J. 70 1993 469 470 (Pubitemid 23342809)
7. R. Rogers, and R. Prpic Profound symptomatic bradycardia associated with combined mibefradil and beta-blocker therapy Med. J. Aust. 169 1998 425 427 (Pubitemid 28497691)
8. International Warfarin Pharmacogenetics Consortium and Klein, T.E. et al. (2009) Estimation of the warfarin dose with clinical and pharmacogenomic data. N. Engl. J. Med. 360, 753-764
9. A.R. Shuldiner Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy J. Am. Med. Assoc. 302 2009 849 857
10. P.J. Neuvonen Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance Clin. Pharmacol. Ther. 80 2006 565 581 (Pubitemid 44908269)
11. G. Cheymol Effects of obesity on pharmacokinetics: implications for drug therapy Clin. Pharmacokinet. 39 2000 215 231
12. H.G. Xie Molecular basis of ethnic differences in drug disposition and response Annu. Rev. Pharmacol. Toxicol. 41 2001 815 850
13. S.M. Huang Drug interaction studies: study design, data analysis, and implications for dosing and labeling Clin. Pharmacol. Ther. 81 2007 298 304
14. L. Zhang Predicting drug-drug interactions: an FDA perspective AAPS J. 11 2009 300 306
15. H.S. Brown Prediction of in vivo drug-drug interactions from in vitro data: factors affecting prototypic drug-drug interactions involving CYP2C9, CYP2D6 and CYP3A4 Clin. Pharmacokinet. 45 2006 1035 1050 (Pubitemid 44436005)
16. L. Li Drug-drug interaction prediction: a Bayesian meta-analysis approach Stat. Med. 26 2007 3700 3721 (Pubitemid 47307744)
17. J. Zhou A new probabilistic rule for drug-dug interaction prediction J. Pharmacokinet. Pharmacodyn. 36 2009 1 18
18. D.S. Wishart DrugBank: a knowledgebase for drugs, drug actions and drug targets Nucleic Acids Res. 36 Suppl. 1 2008 D901 D906
19. D. Weininger SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules J. Chem. Inf. Comput. Sci. 28 1988 31 36 (Pubitemid 18574254)
20. A. Skrbo [Classification of drugs using the ATC system (Anatomic, Therapeutic, Chemical Classification) and the latest changes] Med. Arh. 58 Suppl. 2 2004 138 141
21. M. Kanehisa KEGG for representation and analysis of molecular networks involving diseases and drugs Nucleic Acids Res. 38 Suppl. 1 2010 D355 D360
22. M. Olah WOMBAT: world of molecular bioactivity T.I. Oprea, Chemoinformatics in Drug Discovery 2004 Wiley-VCH 223 240
23. A. Gaulton ChEMBL: a large-scale bioactivity database for drug discovery Nucleic Acids Res. 40 2012 D1100 D1107
24. T. Liu BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities Nucleic Acids Res. 35 Suppl. 1 2007 D198 D201
25. T.E. Klein Integrating genotype and phenotype information: an overview of the PharmGKB project Pharmacogenomics J. 1 2001 167 170 (Pubitemid 33756654)
26. N.P. Tatonetti Data-driven prediction of drug effects and interactions Sci. Transl. Med. 4 2012 125ra31
27. M. Kuhn A side effect resource to capture phenotypic effects of drugs Mol. Syst. Biol. 6 2010 343
28. H.J. Lowe STRIDE-an integrated standards-based translational research informatics platform AMIA Annu. Symp. Proc. 2009 2009 391
29. S.N. Murphy Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2) J. Am. Med. Inform. Assoc. 17 2010 124 130
30. K.E. Thummel, and G.R. Wilkinson In vitro and in vivo drug interactions involving human CYP3A Annu. Rev. Pharmacol. Toxicol. 38 1998 389 430 (Pubitemid 28231501)
31. S. Preissner SuperCYP: a comprehensive database on cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions Nucleic Acids Res. 38 Suppl. 1 2010 D237 D243
32. M. Takarabe Network-based analysis and characterization of adverse drug-drug interactions J. Chem. Inf. Model. 51 2011 2977 2985
33. K.Y.L. Yap An onco-informatics database for anticancer drug interactions with complementary and alternative medicines used in cancer treatment and supportive care: an overview of the OncoRx project Support. Care Cancer 18 2010 883 891
34. A. Chan Electronic database to detect drug-drug interactions between antidepressants and oral anticancer drugs from a cancer center in Singapore: implications to clinicians Pharmacoepidemiol. Drug Saf. 20 2011 939 947
35. Y. Böttiger SFINX-a drug-drug interaction database designed for clinical decision support systems Eur. J. Clin. Pharmacol. 65 2009 627 633
36. I. Segura-Bedmar Using a shallow linguistic kernel for drug-drug interaction extraction J. Biomed. Inform. 44 2011 789 804
37. I. Segura-Bedmar A linguistic rule-based approach to extract drug-drug interactions from pharmacological documents BMC Bioinformatics 12 Suppl. 2 2011 S1
38. P. Thomas Relation extraction for drug-drug interactions using ensemble learning Proceedings of the First Challenge Task on Drug-Drug Interaction Extraction (DDIExtraction 2011) CEUR Workshop Proceedings 2011
39. R. Harpaz Mining multi-item drug adverse effect associations in spontaneous reporting systems BMC Bioinformatics 11 Suppl. 9 2010 S7
40. R. Agrawal Mining association rules between sets of items in large databases ACM SIGMOD Record 22 1993 207 216
41. R. Leone Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy Drug Saf. 33 2010 667 675
42. N.P. Tatonetti Detecting drug interactions from adverse-event reports: interaction between paroxetine and pravastatin increases blood glucose levels Clin. Pharmacol. Ther. 90 2011 133 142
43. N.P. Tatonetti A novel signal detection algorithm for identifying hidden drug-drug interactions in adverse event reports J. Am. Med. Inform. Assoc. 19 2012 79 85
44. B. Percha Discovery and explanation of drug-drug interactions via text mining Pac. Symp. Biocomput. 2012 2012 410
45. L. Tari Discovering drug-drug interactions: a text-mining and reasoning approach based on properties of drug metabolism Bioinformatics 26 2010 i547 i553
46. J.D. Duke Literature based drug interaction prediction with clinical assessment using electronic medical records: novel myopathy associated drug interactions PLoS Comput. Biol. 8 2012 e1002614
47. A. Gottlieb INDI: a computational framework for inferring drug interactions and their associated recommendations Mol. Syst. Biol. 8 2012 592
48. R. Boyce Computing with evidence. Part I. A drug-mechanism evidence taxonomy oriented toward confidence assignment J. Biomed. Inform. 42 2009 979 989
49. R. Boyce Computing with evidence. Part II. An evidential approach to predicting metabolic drug-drug interactions J. Biomed. Inform. 42 2009 990 1003
50. S. Vilar Drug-drug interaction through molecular structure similarity analysis J. Am. Med. Inform. Assoc. 19 2012 1066 1074
51. B.P. Monahan Torsades de pointes occurring in association with terfenadine use J. Am. Med. Assoc. 264 1990 2788 2790
52. H. Okuda Lethal drug interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs Drug Metab. Dispos. 25 1997 270 273 (Pubitemid 27086129)
53. D. Schmassmann-Suhijar Rhabdomyolysis due to interaction of simvastatin with mibefradil Lancet 351 1998 1929 1930 (Pubitemid 28297454)
54. K.E. Ferslew A fatal drug interaction between clozapine and fluoxetine J. Forensic Sci. 43 1998 1082 1085 (Pubitemid 28397197)
55. I.F.N. Hung Fatal interaction between clarithromycin and colchicine in patients with renal insufficiency: a retrospective study Clin. Infect. Dis. 41 2005 291 300 (Pubitemid 41022103)
56. H. Schelleman Warfarin with fluoroquinolones, sulfonamides, or azole antifungals: interactions and the risk of hospitalization for gastrointestinal bleeding Clin. Pharmacol. Ther. 84 2008 581 588
57. L. Francis Fatal toxic myopathy attributed to propofol, methylprednisolone, and cyclosporine after prior exposure to colchicine and simvastatin Clin. Rheumatol. 27 2008 129 131 (Pubitemid 350182692)